$CAPR News Capricor Therapeutics to Present First Quarter 2021 Financial Results and Recent Corporate Update on May 13 Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform